Report Detail

Medical Devices & Consumables Global Drug Eluting Implant Market Research Report 2021

  • RnM4322030
  • |
  • 10 June, 2021
  • |
  • Global
  • |
  • 124 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Drug Eluting Implant Market Overview

  • 1.1 Product Overview and Scope of Drug Eluting Implant
  • 1.2 Drug Eluting Implant Segment by Type
    • 1.2.1 Global Drug Eluting Implant Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Rapamycin Eluting Implant
    • 1.2.3 Paclitaxel Eluting Implant
    • 1.2.4 Everolimus Eluting Implant
    • 1.2.5 Others
  • 1.3 Drug Eluting Implant Segment by Application
    • 1.3.1 Global Drug Eluting Implant Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Ambulatory Surgical Centers
    • 1.3.5 Others
  • 1.4 Global Drug Eluting Implant Market Size Estimates and Forecasts
    • 1.4.1 Global Drug Eluting Implant Revenue 2016-2027
    • 1.4.2 Global Drug Eluting Implant Sales 2016-2027
    • 1.4.3 Drug Eluting Implant Market Size by Region: 2016 Versus 2021 Versus 2027

2 Drug Eluting Implant Market Competition by Manufacturers

  • 2.1 Global Drug Eluting Implant Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Drug Eluting Implant Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Drug Eluting Implant Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Drug Eluting Implant Manufacturing Sites, Area Served, Product Type
  • 2.5 Drug Eluting Implant Market Competitive Situation and Trends
    • 2.5.1 Drug Eluting Implant Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Drug Eluting Implant Players Market Share by Revenue
    • 2.5.3 Global Drug Eluting Implant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Drug Eluting Implant Retrospective Market Scenario by Region

  • 3.1 Global Drug Eluting Implant Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Drug Eluting Implant Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Drug Eluting Implant Market Facts & Figures by Country
    • 3.3.1 North America Drug Eluting Implant Sales by Country
    • 3.3.2 North America Drug Eluting Implant Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Drug Eluting Implant Market Facts & Figures by Country
    • 3.4.1 Europe Drug Eluting Implant Sales by Country
    • 3.4.2 Europe Drug Eluting Implant Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Drug Eluting Implant Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Drug Eluting Implant Sales by Region
    • 3.5.2 Asia Pacific Drug Eluting Implant Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 China Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Drug Eluting Implant Market Facts & Figures by Country
    • 3.6.1 Latin America Drug Eluting Implant Sales by Country
    • 3.6.2 Latin America Drug Eluting Implant Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Drug Eluting Implant Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Drug Eluting Implant Sales by Country
    • 3.7.2 Middle East and Africa Drug Eluting Implant Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Drug Eluting Implant Historic Market Analysis by Type

  • 4.1 Global Drug Eluting Implant Sales Market Share by Type (2016-2021)
  • 4.2 Global Drug Eluting Implant Revenue Market Share by Type (2016-2021)
  • 4.3 Global Drug Eluting Implant Price by Type (2016-2021)

5 Global Drug Eluting Implant Historic Market Analysis by Application

  • 5.1 Global Drug Eluting Implant Sales Market Share by Application (2016-2021)
  • 5.2 Global Drug Eluting Implant Revenue Market Share by Application (2016-2021)
  • 5.3 Global Drug Eluting Implant Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Boston Scientific
    • 6.1.1 Boston Scientific Corporation Information
    • 6.1.2 Boston Scientific Description and Business Overview
    • 6.1.3 Boston Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Boston Scientific Drug Eluting Implant Product Portfolio
    • 6.1.5 Boston Scientific Recent Developments/Updates
  • 6.2 Medtronic
    • 6.2.1 Medtronic Corporation Information
    • 6.2.2 Medtronic Description and Business Overview
    • 6.2.3 Medtronic Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Medtronic Drug Eluting Implant Product Portfolio
    • 6.2.5 Medtronic Recent Developments/Updates
  • 6.3 Abbott
    • 6.3.1 Abbott Corporation Information
    • 6.3.2 Abbott Description and Business Overview
    • 6.3.3 Abbott Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Abbott Drug Eluting Implant Product Portfolio
    • 6.3.5 Abbott Recent Developments/Updates
  • 6.4 Lepu Medical
    • 6.4.1 Lepu Medical Corporation Information
    • 6.4.2 Lepu Medical Description and Business Overview
    • 6.4.3 Lepu Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Lepu Medical Drug Eluting Implant Product Portfolio
    • 6.4.5 Lepu Medical Recent Developments/Updates
  • 6.5 B. Braun Melsungen
    • 6.5.1 B. Braun Melsungen Corporation Information
    • 6.5.2 B. Braun Melsungen Description and Business Overview
    • 6.5.3 B. Braun Melsungen Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 B. Braun Melsungen Drug Eluting Implant Product Portfolio
    • 6.5.5 B. Braun Melsungen Recent Developments/Updates
  • 6.6 MicroPort Scientific
    • 6.6.1 MicroPort Scientific Corporation Information
    • 6.6.2 MicroPort Scientific Description and Business Overview
    • 6.6.3 MicroPort Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 MicroPort Scientific Drug Eluting Implant Product Portfolio
    • 6.6.5 MicroPort Scientific Recent Developments/Updates
  • 6.7 Cook Medical
    • 6.6.1 Cook Medical Corporation Information
    • 6.6.2 Cook Medical Description and Business Overview
    • 6.6.3 Cook Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Cook Medical Drug Eluting Implant Product Portfolio
    • 6.7.5 Cook Medical Recent Developments/Updates
  • 6.8 Terumo
    • 6.8.1 Terumo Corporation Information
    • 6.8.2 Terumo Description and Business Overview
    • 6.8.3 Terumo Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Terumo Drug Eluting Implant Product Portfolio
    • 6.8.5 Terumo Recent Developments/Updates
  • 6.9 Biosensors International
    • 6.9.1 Biosensors International Corporation Information
    • 6.9.2 Biosensors International Description and Business Overview
    • 6.9.3 Biosensors International Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Biosensors International Drug Eluting Implant Product Portfolio
    • 6.9.5 Biosensors International Recent Developments/Updates
  • 6.10 Balton
    • 6.10.1 Balton Corporation Information
    • 6.10.2 Balton Description and Business Overview
    • 6.10.3 Balton Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Balton Drug Eluting Implant Product Portfolio
    • 6.10.5 Balton Recent Developments/Updates
  • 6.11 AlviMedica Medical Technologies
    • 6.11.1 AlviMedica Medical Technologies Corporation Information
    • 6.11.2 AlviMedica Medical Technologies Drug Eluting Implant Description and Business Overview
    • 6.11.3 AlviMedica Medical Technologies Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 AlviMedica Medical Technologies Drug Eluting Implant Product Portfolio
    • 6.11.5 AlviMedica Medical Technologies Recent Developments/Updates
  • 6.12 Biotronik
    • 6.12.1 Biotronik Corporation Information
    • 6.12.2 Biotronik Drug Eluting Implant Description and Business Overview
    • 6.12.3 Biotronik Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Biotronik Drug Eluting Implant Product Portfolio
    • 6.12.5 Biotronik Recent Developments/Updates
  • 6.13 Shandong JW Medical
    • 6.13.1 Shandong JW Medical Corporation Information
    • 6.13.2 Shandong JW Medical Drug Eluting Implant Description and Business Overview
    • 6.13.3 Shandong JW Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Shandong JW Medical Drug Eluting Implant Product Portfolio
    • 6.13.5 Shandong JW Medical Recent Developments/Updates
  • 6.14 Sino Medical
    • 6.14.1 Sino Medical Corporation Information
    • 6.14.2 Sino Medical Drug Eluting Implant Description and Business Overview
    • 6.14.3 Sino Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Sino Medical Drug Eluting Implant Product Portfolio
    • 6.14.5 Sino Medical Recent Developments/Updates
  • 6.15 Beijing AMSINO
    • 6.15.1 Beijing AMSINO Corporation Information
    • 6.15.2 Beijing AMSINO Drug Eluting Implant Description and Business Overview
    • 6.15.3 Beijing AMSINO Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Beijing AMSINO Drug Eluting Implant Product Portfolio
    • 6.15.5 Beijing AMSINO Recent Developments/Updates

7 Drug Eluting Implant Manufacturing Cost Analysis

  • 7.1 Drug Eluting Implant Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Drug Eluting Implant
  • 7.4 Drug Eluting Implant Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Drug Eluting Implant Distributors List
  • 8.3 Drug Eluting Implant Customers

9 Drug Eluting Implant Market Dynamics

  • 9.1 Drug Eluting Implant Industry Trends
  • 9.2 Drug Eluting Implant Growth Drivers
  • 9.3 Drug Eluting Implant Market Challenges
  • 9.4 Drug Eluting Implant Market Restraints

10 Global Market Forecast

  • 10.1 Drug Eluting Implant Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Drug Eluting Implant by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Drug Eluting Implant by Type (2022-2027)
  • 10.2 Drug Eluting Implant Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Drug Eluting Implant by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Drug Eluting Implant by Application (2022-2027)
  • 10.3 Drug Eluting Implant Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Drug Eluting Implant by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Drug Eluting Implant by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Rapamycin Eluting Implant
    Paclitaxel Eluting Implant
    Everolimus Eluting Implant
    Others

    Segment by Application
    Hospitals
    Clinics
    Ambulatory Surgical Centers
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    China Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Boston Scientific
    Medtronic
    Abbott
    Lepu Medical
    B. Braun Melsungen
    MicroPort Scientific
    Cook Medical
    Terumo
    Biosensors International
    Balton
    AlviMedica Medical Technologies
    Biotronik
    Shandong JW Medical
    Sino Medical
    Beijing AMSINO


    Summary:
    Get latest Market Research Reports on Drug Eluting Implant. Industry analysis & Market Report on Drug Eluting Implant is a syndicated market report, published as Global Drug Eluting Implant Market Research Report 2021. It is complete Research Study and Industry Analysis of Drug Eluting Implant market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,053.20
    3,079.80
    4,106.40
    2,389.60
    3,584.40
    4,779.20
    318,072.00
    477,108.00
    636,144.00
    212,251.00
    318,376.50
    424,502.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report